
Roche Wants Tissue Images to Do More in Drug Development
Roche’s latest PathAI update connects laboratory workflows with biomarker research and clinical trials, building on its May acquisition agreement.
The newest enterprise AI stories, analysis and reporting from Deployed.

Roche’s latest PathAI update connects laboratory workflows with biomarker research and clinical trials, building on its May acquisition agreement.

“Kosmos produced in a morning what would have taken me 3 months of work to complete,” said Pichai Raman, senior director, computational biology at Incyte.

Google is offering 10,000 selected scientists its highest usage tier free for six months, subject to eligibility and capacity.

The warehouse operator plans to extend Digit’s commercial deployment in early 2027, starting with the current robot before migrating to its next generation.

"I couldn't justify the time or the cost."

"Our AI pipeline is focused on shifting from AI testing to adoption and then to scaling impact."

"A return on token costs of 5 to 10 times, and no negative impact on customer NPS."

"Orders are growing even faster at 3.3x."

“Most cancers will be gone in five years, and certainly in 10, they’re going to be gone,” says Oracle’s executive chairman and chief technology officer, Larry Ellison.

Tremont AI’s research collaboration with AstraZeneca will develop and evaluate foundation models for preclinical toxicologic pathology, where rare tissue changes can be difficult to distinguish from normal variation.

"Customers are solely responsible for supervising their authorized representatives and delegates, along with those parties' AI agents."

AI agents are helping engineers resolve robot-related problems in 7.9 days, down from 21.5 days. The company is now targeting a programming-cost reduction of more than 50%.

"Right now, our view is that AI is largely reshaping travel discovery."

"The platform gives our fraud specialists the information they need in one place."

An early procurement-requisition agent was built in an afternoon by a functional consultant who had never used the tool before.

Measurable AI results in pharma manufacturing nearly doubled to 53%.

Choice reported Q3 2026 adjusted EBITDA of about $193 million, up 1% year over year.

Alexion, AstraZeneca's rare disease unit, is hiring a Head of AI in Boston to set enterprise AI strategy across research, regulatory, operations and commercial. AstraZeneca already runs a central Enterprise AI unit under a chief digital, data and AI officer that covers the same functions. The question is whether rare disease needs its own AI leader, or whether the parent risks building two AI agendas.

Pool-equipment maker Hayward Holdings is hiring a VP of Enterprise Architecture & AI Innovation in Charlotte who will own architecture standards, the AI strategy, governance and the innovation roadmap in one job. Most manufacturers give AI to a data team or a business-led office. Hayward is betting that a mid-cap with plants on four continents and a connected-product line needs AI built into its architecture from the start.

Walmart has published what nearly 1.7 million associates told it about AI, the largest employer-run study of AI at work so far. Office staff are excited and frontline workers are confident with digital tools, but the two groups were measured on different questions, so the comparison that matters most for retail's biggest workforce is not in the report.